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ABSTRACT:  Amrithadi Churnam – a compound ayurvedic preparation made up of Tinospora 
cordifolia, Salacia prenoides, Curcuma longa, Tribulus terrestris and Emblica Officinalis was 
screened for its antidiabetic activity.  From the studies it could be established that Amrithadi 
churnam at a dose level of 100mg/kg b.w. was the optimum dose in alloxan diabetic rats.  No 
toxic effects were observed as evidenced by the study of liver enzymes and blood haematoerit.  
An extra pancreatic role of the drug cannot be rulled out, since it (100 mg/kg b.w) produced 
significant decrease in blood sugar level in alloxan diabetic rats. 
 
INTRODUCTION 
 
Amrithadi churnam is a compound 
ayurvedic preparation made from five 
constituent drugs viz. Tyinospora cordifolia 
(San.  Guduchi), Salacia prenoides (San. 
Ekanayakam,) Curuma longa (San. 
Haridra), Tribulus terrestris (San. Goksura) 
and  Phyllanthus emblica (San.Amalaki).   
The powder is known to be administered to 
diabetic patients by many ayurvedic 
physicians to cure the metabolic disorder.   
However, scientific evidence on the 
antidiabetic activity of the powder as such is 
lacking.  The individual constants in the 
powder have been attributed several 
medicinal properties from very early times.  
T. Cordifolia  has been mentioned in 
Ayurvedic literature as an ingredient in 
several compound preparations used in 
general  debility, dyspepsia, fever and 
urinary disorders (Wealth of India, 1976).   
Antiviral effect of the plant against Ranikhet 
disease of the poultry has been reported by 
many workers (Chopra et. al 1958, Dastur, 
1951; Kirtikar et al 1935).  The active 
principle of the drug has been found to 
produce in vitro inhibitory effect on 
Mycobacterium tuberculosis   (Annual 
report, ICMR. 1968 – 69).  The acute and 
chronic effects of feeding plant extracts on 
blood sugar, glucose tolerance etc. were 
studied in animals and the aqueous and 
alcoholic extracts were found to reduce 
blood sugar levels.  The drug has a 
suggested  effect on endogenous insulin 
secretion and inhibition of peripheral 
glucose release.  (Mehta et al., 1965, Gupta 
et al 1967).  Roots of Salaciaprenoides  
have been reported to be used as an 
antidiabetic drug in the indigenous system of 
medicine.  The medicinally active 
components of the root bark have been 
characterized by several workers (Dash & 
Bedi 1967; Bhatnagar  et al,  1954, 
Ramanathan et al, 1960; Krishnan et al, 
1967; Pillay et al 1957). Earlier studies 
conducted with three species of Salacia also 
indicated the hypoglycemic activity of the 
plant (Nair et al 1981).  C. longa has been 
mentioned in ancient literature as a 
stomachic, tonic and blood purifier.  (Wealth 
of India, 1950).  Chemical characterization 
of the rhizome was made by several workers Pages  280 - 285 
 
(Health Bulletin, 1941; Mayer 35 al, 1943) 
and choleretic action of its essential oil has 
been attributed to P-tolymlthylcarbional  T. 
Terrestris  is being used for the treatment of 
renal calculus and painful micturition.  The 
diuretic activity of the drug has been studied 
in detail.  (Santhakumar et al, 1967).  The 
seeds were reported to contain an alkaloid to 
which the diuretic effect was ascribed.   
(Wealth of India. 1976).  The root extract is 
a constituent of many Ayurvedic 
preparations like Dasamoolarishta  and 
Amrithaprasa ghritha prescribed for several 
disease. (Koman, 1919 Rama Rao, 1914; 
Kirtika et al, 1935, Pradhan, 1963).  The 
medicinal properties of Amla fruit (Kirtikar 
et al, 1935; Nadkarni, 1914; Koman, 1918) 
are well documented and it form constituent 
of many Ayurvedic preparations. 
 
Although individual components of 
Amrithadi churnam have been ascribed for 
many therapeutic effects, the synergistic 
action of remains relatively unknown.  The 
antidiabetic action of the powder was 
studied in albino rats in comparison to the 
effect of standard hypoglycemic drugs 
tolbutamide and phenformin. 
 
MATERIALS AND METHODS 
 
Adult albinos rats (Sprage-Dowley strain) 
weighing 180 –  200g. were used for the 
study.  Before the start of the experiment 
animals were fasted overnight and blood 
sugar values were noted. 
 
Blood was collected by the eye puncture 
method using clean capillary tube.  The 
animals were fed standard feed and water 
was available ad-libitum. 
 
Healthy male albino rats from the colony 
were made diabetic by the single rapid ip 
injection of 120 mg/kg body weight of 
alloxan monohydrate.  (5% w/v in distilled 
water) After 3 days the fasting blood sugar 
levels were rechecked and diabetic animals 
were selected on the elevated sugar values.  
These were grouped into six each containing 
5 rats.  Group Administered distilled water 
served as control Group II-IV were given 
Amrthidai churnam at dose levels of 50mg. 
100mg and 200 mg/kg. body weight.  Group 
V and VI were given tolbutamide (250 
mg/kg. body weight).  Group V and VI were 
given tolbutamide (250 mg/kg b.w) and 
phenformin (20 mg/kg b.w) served as 
reference standards.  Respective drugs were 
administered for 4 weeks and the overnight 
fasted animals were sacrificed.  Blood and 
liver samples were collected for the 
biochemical analyses. 
 
Blood sugar was determined by the method 
of Astoor and King (1954).  Serum total 
proteins  were determined using Biuret 
method (1945).  Serum and liver 
transaminase (GOT and GPT) were 
determined by the method of Reitman & 
Frankel (1957).  Blood hematocrit was 
recorded following standard procedures. 
 
RESULTS AND DISCUSSION 
 
The initial fasting blood sugar values of 
alloxan diabetic rats ranged from 206 – 305 
mg/ 100 ml.  (Table I).  It was found that 
administration of Amrithadi churnam  at a 
dose level of 50 mg/kg b.w. could bring 
down the blood sugar level to 152.7 ± 9.99 
mg/100ml.  A dose level of 100 mg/kg b.w. 
could significantly reduce the 
hyperglycemia observed before the 
treatment (Table. I).  However the higher 
dose level of 200 mg/kg b.w. could not 
further bring  down the blood sugar.  Its 
effective was comparable to the lowest dose 
level tried.  From the studies it could be 
established that 100 mg/kg b.w. was the 
optimum dose level in rats.  Only non 
significant hypoglycemeic changes were Pages  280 - 285 
 
noted in rats given tolbutamide while 
phenoformin exhibited a significant 
hypoglycemic effect (Table I).  This was 
observed from the results of earlier studies 
also (Nair et. al. 1986). 
 
Serum and liver protein changes in rats 
given Amrithadi churnam are given in Table 
II.   It could be seen that at the lower dose 
levels the drug produced no effect on serum 
protein levels.  However the higher dose 
level produced significant decrease in the 
serum protein liver protein remained 
unaffected at all dose levels (Table II). 
 
The pattern of changes in serum and liver 
transaminase depicted in Table III to show 
that the drug did not alter the serum and 
liver glutamate oxalo acetate transaminase 
activity.  While the serum GPT remained 
unaffected at the three dose levels tried, liver 
GPT activity was considerably reduced at 
the lowest dose level 50 mg/kg b.w. tried.  
However the optimum dose level of the drug 
as judged from the maximum hypoglycemic 
effect being 100mg / kg b.w, this decrease in 
GPT activity of liver has little significance. 
 
Tolbutamide was found to be ineffective in 
alloxan diabetic animals. Since alloxan 
administration has bee reported to damage 
the  B-cells of langerhans of pancreas, the 
site of insulin release.  The hypoglycemic 
effect of tolbutamide is mainly through 
enhancing insulin release in normal diabetic 
condition.  (Jenkin’s et al; 1978) Phenformin 
on the other hand increase glucose uptake by 
peripheral tissues and accelerates anaerobic 
glycolysis through an uncoupling of 
exudative phosphorylation (Nair and 
Santhakumar,1986). 
 
The hypoglycemic effect of Amrithati 
churnam    observed in alloxan diabetic 
animals indicates an extract pancreatic 
action of the drug.  The exact mode of action 
of the drug needs further investigations.  The 
serum and liver protein levels as well as 
transaminase activities indicate the nontoxic 
nature of the drug at lower level of 50 mg 
and 100 mg/kg b.w.  Also the blood 
haemtocrit indicates the non-toxic nature of 
thedrug (Table IV).  The study shows that 
Amrithadi churnam  has got potent 
antidiabetic / hypolycaemic effect at the 
optimum dose level of 100 mg/kg b.w in 
rats. 
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TABLE – I 
Effect of Amirthadi Churnam on Blood Glucose level in alloxan Diabetic Rats. 
 
Group / Drug dose levels  Initial blood Sugar 
mg/100ml 
Blood glucose levels after 4 
weeks mg/100ml 
Group I 
(Diabetic control) 
Group II 
50 mg/kg b.w 
Group III 
100 mg/kg b.w. 
Group IV 
200 mg/kg b.w 
Group V 
Tolbutamide 
Group VI 
Phenformin 20 mg/kg b.w 
230.8 
± 22.63 
207.04 
± 14.15 
206.2 
± 15.49 
233.8 
± 13.06 
305.5 
±18.2 
277.8 
± 13.8 
220.4 
±17.79 
152.7 
±9.99 ** 
126.54 
±5.93 ** 
152.84  
±10.28 ** 
290.30 
± 8.5 
147.5 
±15.9 *** 
  **   P<.01 
  *** P<.001 
  Figures without superscripts are insignificant 
  
TABLE – II 
Serum and Liver protein values in Alloxan diabetic rats administered Amrithadi Churnam 
 
Group / Drug dose levels  Serum g/100ml  Liver g/100gm wet tissue 
Group I 
(Diabetic control) 
Group II 
50 mg/kg b.w 
Group III 
100 mg/kg b.w. 
Group IV 
200 mg/kg b.w 
.P<.001 
7.85 
± 0.23 
7.92 
± 0.35 
7.18 
± 0.32 
6.14 
± 0.30 
 
19.36 
±1.25 
18.90 
±1.26  
19.06 
±1.88  
162.88  
±0.55  
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TABLE III 
Serum and liver got and GPT activities in rats administered Amrithadi churnam 
 
Group / Drug  GOT Serum
1  Liver
2  GPT Serum
1  Liver
2 
Group I 
(Diabetic control) 
Group II 
50 mg/kg b.w 
Group IV 
200 mg/kg b.w 
9.82 
±0.62 
10.08 
±0.99 
9.88 
±0.50 
3.35 
±0.38 
2.76 
±0.44 
3.38 
±0.36 
24.25 
±2.18 
24.16 
±0.28 
21.86 
±1.70 
28.27 
±1.60 
23.08 
±1.58* 
25.34 
±1.86 
 
P <0.05 
1. m pyruvate liberated/min/litre at 37
0C. 
2. m pyruvate liberated /min/mg protein at 37
0C 
 
 
TABLE IV 
Blood Hematocrit in alloxan rats administered Amrithadi churnam 
 
Group / Drug 
Dose levels 
Total count 
(TC) cell /c.m.m 
Differential count (DC) 
Polymorph          
(P) 
Lymphocytes 
(L) 
Eosinophile        
(E) 
Group I 
(Diabetic control) 
Group II 
50 mg/kg b.w 
Group III 
100 mg/kg b.w 
Group IV 
200 mg/kg b.w 
6975 
±100.3 
7838 
±430.2 
5835 
±330.6 
6836 
±530.2 
43 
±3.5 
38 
±4.3 
51 
±2.60 
45 
±3.2 
47 
±2.8 
49 
±5.6 
43 
±3.6 
47 
±4.1 
10 
±.50 
13 
±.95 
6 
±.76 
8 
±0.70 
 
All are non significant values. 
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